Mood disorder clinical trials rely upon clinician ratings for key measures of efficacy.
Ensuring the eligibility of patients is a critical success factor, and when ratings are also used as eligibility criteria this can present challenges.
In episode two of our "Clinical Viewpoints" video series, Gary Sachs, MD, Clinical Vice President, Bipolar Disease and Mood Disorders, discusses how to measure diagnostic confidence and leverage this to improve the ability to detect treatment-related effects in mood disorder trials.
